vs
Side-by-side financial comparison of Avidia Bancorp, Inc. (AVBC) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Avidia Bancorp, Inc. is the larger business by last-quarter revenue ($26.8M vs $18.3M, roughly 1.5× ROCKWELL MEDICAL, INC.). Avidia Bancorp, Inc. runs the higher net margin — 22.9% vs -3.0%, a 25.9% gap on every dollar of revenue. Avidia Bancorp, Inc. produced more free cash flow last quarter ($24.1M vs $2.2M).
Avidia Bank is an American mutual community bank headquartered in Hudson, Massachusetts. It was founded in 2007 when it was formed by a merger between Hudson Savings Bank and Westborough Bank.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
AVBC vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.8M | $18.3M |
| Net Profit | $5.3M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 33.3% | -2.2% |
| Net Margin | 22.9% | -3.0% |
| Revenue YoY | — | -25.6% |
| Net Profit YoY | — | 26.7% |
| EPS (diluted) | — | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.8M | $18.3M | ||
| Q3 25 | $28.0M | $15.9M | ||
| Q2 25 | $25.9M | $16.1M | ||
| Q1 25 | $22.9M | $18.9M | ||
| Q4 24 | — | $24.7M | ||
| Q3 24 | — | $28.3M | ||
| Q2 24 | — | $25.8M | ||
| Q1 24 | — | $22.7M |
| Q4 25 | $5.3M | $-554.0K | ||
| Q3 25 | $-907.0K | $-1.8M | ||
| Q2 25 | $3.9M | $-1.5M | ||
| Q1 25 | $-11.6M | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $343.0K | ||
| Q1 24 | — | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 33.3% | -2.2% | ||
| Q3 25 | -7.0% | -9.9% | ||
| Q2 25 | 19.4% | -8.4% | ||
| Q1 25 | -72.0% | -7.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | -5.8% |
| Q4 25 | 22.9% | -3.0% | ||
| Q3 25 | -3.2% | -11.0% | ||
| Q2 25 | 15.0% | -9.3% | ||
| Q1 25 | -50.5% | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | -7.6% |
| Q4 25 | — | $-0.01 | ||
| Q3 25 | $-0.05 | $-0.05 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $275.0M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $379.0M | $37.0M |
| Total Assets | $2.8B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $275.0M | $10.7M | ||
| Q3 25 | $208.3M | $13.6M | ||
| Q2 25 | $592.5M | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | $379.0M | $37.0M | ||
| Q3 25 | $372.0M | $37.0M | ||
| Q2 25 | $191.4M | $30.4M | ||
| Q1 25 | $186.1M | $31.5M | ||
| Q4 24 | — | $32.6M | ||
| Q3 24 | — | $29.1M | ||
| Q2 24 | — | $23.5M | ||
| Q1 24 | — | $20.6M |
| Q4 25 | $2.8B | $57.1M | ||
| Q3 25 | $2.8B | $57.5M | ||
| Q2 25 | $3.0B | $52.6M | ||
| Q1 25 | $2.7B | $54.0M | ||
| Q4 24 | — | $59.2M | ||
| Q3 24 | — | $57.1M | ||
| Q2 24 | — | $53.0M | ||
| Q1 24 | — | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.4M | $2.3M |
| Free Cash FlowOCF − Capex | $24.1M | $2.2M |
| FCF MarginFCF / Revenue | 89.9% | 12.0% |
| Capex IntensityCapex / Revenue | 16.0% | 0.5% |
| Cash ConversionOCF / Net Profit | 5.32× | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.2M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.4M | $2.3M | ||
| Q3 25 | $24.1M | $-1.3M | ||
| Q2 25 | $-2.3M | $1.8M | ||
| Q1 25 | $-2.2M | $-3.5M | ||
| Q4 24 | — | $865.0K | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | — | $-2.4M |
| Q4 25 | $24.1M | $2.2M | ||
| Q3 25 | $23.3M | $-1.5M | ||
| Q2 25 | $-3.3M | $1.7M | ||
| Q1 25 | $-3.9M | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | 89.9% | 12.0% | ||
| Q3 25 | 83.2% | -9.6% | ||
| Q2 25 | -12.8% | 10.5% | ||
| Q1 25 | -16.9% | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | 16.0% | 0.5% | ||
| Q3 25 | 3.1% | 1.4% | ||
| Q2 25 | 3.7% | 1.0% | ||
| Q1 25 | 7.2% | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 5.32× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.60× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVBC
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
